查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439906

全球眼科手術設備市場：洞察、競爭格局、市場預測：2030 年

Ophthalmic Surgical Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2022年全球眼科手術設備市場規模為89.1億美元。 預計到 2030 年，市場規模將達到 119.7 億美元，2024 年至 2030 年的預測期間複合年增長率為 5.09%。 由於青光眼、白內障和屈光不正等各種眼科疾病的盛行率不斷增加等因素，眼科手術設備市場正經歷顯著的市場成長。 此外，老年人口的增加、糖尿病盛行率的上升以及其他眼部疾病的危險因子預計將推動眼科手術設備市場的發展。

推動眼科手術設備市場的關鍵因素之一是白內障、青光眼和屈光不正等視力損害疾病的增加。

例如，根據衛生和家庭福利部2023年提供的數據，青光眼是印度不可逆性失明的主要原因之一，每年影響至少1200萬人。據稱，近120萬人患有青光眼。人們受到這種疾病的影響而失明。

根據世界青光眼協會2022的數據，預計2020年全球將有7,960萬人患有青光眼。 此外，到 2040 年，這一數字預計將增加到 1.118 億。

本報告考察了全球眼科手術設備市場，並提供了市場概述，包括按產品類型、應用、最終用戶、地區和參與市場的公司概況劃分的趨勢。

目錄

第1章眼科手術設備市場報告簡介

第2章眼科手術設備市場摘要

第3章監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第4章眼科手術設備市場主要因素分析

  • 眼科手術設備市場驅動因素
  • 眼科手術設備市場的抑制因素與挑戰
  • 眼科手術設備市場機遇

第5章眼科手術設備市場波特五力分析

第6章COVID-19對眼科手術設備市場的影響分析

第7章眼科手術設備市場概況

  • 依產品類型
  • 依用途
  • 按最終用戶
  • 按地區

第8章眼科手術設備市場全球公司份額分析 - 3至5家主要公司

第9章眼科手術設備市場公司及產品概況

  • Bausch & Lomb Incorporated
  • Topcon Corporation
  • Johnson & Johnson
  • Carl Zeiss AG
  • Alcon Inc
  • Lumenis Ltd
  • Hoya Corporation
  • Ellex Medical Laser Ltd
  • STAAR Surgical Company
  • Ziemer Ophthalmic Systems AG
  • Glaukos Corporation.
  • AbbVie.
  • New World Medical, Inc.
  • Oertli Instrumente AG
  • NIDEK CO., LTD.
  • IRIDEX Corporation
  • HumanOptics
  • Surgical Holdings.
  • Madhu Instruments Pvt. Ltd
  • GWS Surgicals LLP

第10章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡我們

Product Code: DIMDCL0584

OPHTHALMIC SURGICAL DEVICES MARKET BY PRODUCT TYPE (IMPLANTS & STENTS [INTRAOCULAR LENSES {IOLS}, GLAUCOMA DRAINAGE IMPLANTS, AND OTHERS], VISCOELASTICS (OVDS), LASER SURGERY DEVICES, AND OTHERS), BY APPLICATION (CATARACT SURGERY, GLAUCOMA SURGERY, VITREORETINAL SURGERY, REFRACTIVE SURGERY, AND OTHERS), BY END-USER (HOSPITALS & CLINICS, SPECIALTY CENTERS, AND OTHERS), AND BY GEOGRAPHY IS EXPECTED TO ADVANCE AT A RESPECTABLE CAGR FORECAST till 2030 OWING TO THE INCREASING PREVALENCE OF VARIOUS OPTHALMIC DISORDERS SUCH AS CATARACT, GLAUCOMA, AMONG OTHERS, RISING PREVALENCE OF DIABETES, AND ESCALTING BURDEN OF GERATRIC POPULATION ACROSS THE GLOBE

The global ophthalmic surgical devices market was valued at USD 8.91 billion in 2022 and will grow at a CAGR of 5.09% during the forecast period from 2024 to 2030 in order to reach USD 11.97 billion by 2030. The ophthalmic surgical devices market is observing a remarkable market growth due to the factors such as the Growing prevalence of various ophthalmic disorders such as glaucoma, cataract, refractive errors, and others. Moreover, the rising burden of geriatric population, the rising prevalence of diabetes, and other risk factors for ophthalmic disorders will aid in driving the market for ophthalmic surgical devices. Additionally, the rising awareness about the vision impairment, surging technological advancements in the devices along with the increasing product launches and approvals, presence of key players in the market, and other factors will create a requisite for the ophthalmic surgical devices in the market. Therefore, the market for ophthalmic surgical devices is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

OPHTHALMIC SURGICAL DEVICES MARKET DYNAMICS:

One of the key aspect for driving the ophthalmic surgical devices market is the rising number of vision impairment disorders such as cataract, glaucoma, refractive errors, and others.

For instance, as per the figures provided by the Ministry of Health and Family Welfare (2023), it was stated that in India, glaucoma is one of the leading cause of irreversible blindness with at least 12 million people affected and nearly 1.2 million people blind from the disease, every year.

Also, as per the World Glaucoma Association 2022, it was estimated that 79.6 million individuals had glaucoma in 2020, globally. Moreover, this number is likely to increase to 111.8 million individuals in 2040, globally.

Furthermore, as per the World Health Organization 2022, at least 2.2 billion people had a near or distance vision impairment, in 2020, across the globe.

Thus, from the above sources it can be analyzed that the prevalence and incidence of various ophthalmic disorders is quite high across the globe, ultimately leading to the increased demand of ophthalmic surgical devices used in the treatment and management of the afore-said disorders, thereby increasing the overall market growth of the ophthalmic surgical devices.

Moreover, the rising burden of geriatric population, the increasing prevalence of diabetes and diabetes retinopathy, and other factors will drive the market of ophthalmic surgical devices. According to the latest study conducted by Center for Disease Prevention and Control (CDC), it was estimated that nearly 4.2 million adults had diabetic retinopathy and nearly 655,000 had vision threatening diabetic retinopathy. Thus, the increasing prevalence of diabetes and diabetes retinopathy will spur the demand of ophthalmic surgical devices as these devices can be used in curing the blindness caused due to diabetic retinopathy, thereby bolstering the overall market growth of the ophthalmic surgical devices in the upcoming years.

Also, an increase in the investment by the key players in the ophthalmic devices sector is expected to boost the growth of the global ophthalmology surgical devices throughout the forecast period.

Therefore, the factors stated above collectively will drive the overall ophthalmic surgical devices market during the forecast period from 2024-2030.

However, the higher cost of surgical devices, complications related to surgical procedures, unfavorable reimbursement policies pertaining to the ophthalmic surgery industry, and others may prove to be challenging factors for ophthalmic surgical devices market growth.

The ophthalmic surgical devices market was negatively impacted during the period of COVID- 19 pandemic. In order to curb the spread of infection the government across the globe imposed strict lockdown rules, resulting in the shortage of supply chains, raw materials, and other resources in the market, leading to the decreased manufacturing of all the medical devices. Moreover, the patients and physicians postponed many elective surgeries, laser therapies, and other ophthalmic therapies in order to stop the spread of the infection, thereby decreasing the number of in-patient visits in hospitals and clinics. However, vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape, which has initiated the process of resumption of regular healthcare services such as regular out-patients visits for treatments and sessions in hospitals and clinics, thereby bringing the demand for products on track in the ophthalmic surgical devices market.

OPHTHALMIC SURGICAL DEVICES MARKET SEGMENT ANALYSIS:

Ophthalmic Surgical Devices Market by Product Type (Implants & Stents [Intraocular Lenses {IOLS}, Glaucoma Drainage Implants, and Others], Viscoelastics (OVDS), Laser Surgery Devices, and Others), By Application (Cataract Surgery, Glaucoma Surgery, Vitreoretinal Surgery, Refractive Surgery, and Others), By End-User (Hospitals & Clinics, Specialty Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the application segment of the ophthalmic surgical devices market, the cataract surgery segment is expected to have a significant revenue share in the year 2023. This was primarily owing to the rising number of cataract surgery owing to the rising prevalence of cataract, availability of technological advanced products in the market, rising product launches and approvals in the market, and other advantages offered by the segment.

For instance, as per the latest study done by National Institute for Health and Clinical Excellence (NICE) and the NHS, approximately 330,000 cataract operations are performed each year in England alone.

Further, according to the National Ophthalmology Database 2019, cataract surgery emerged as the most common surgical procedure in the United Kingdom with 414,000 cataract operations during 2017-2018.

Also, according to the latest study conducted by Ophthalmology Physicians & Surgeons, there are more than 2 million cataract surgeries performed in the United States each year.

Thus, the above sources concluded that the number of cataract surgeries is high across the globe, thereby leading the increase demand of cataract surgery devices.

Moreover, the increasing product launches and approvals in the market will propel the demand of the segment. For instance, in July 2022, Johnson & Johnson (J&J) Vision has globally launched its phacoemulsification (phaco) system, developed to provide surgeons with improved efficiency and comfort during cataract surgery. The VERITAS Vision System features hybrid fluidics technology, which lowers post-occlusion surge to preserve intraocular structures and offer better chamber stability.

Therefore, owing to the above-mentioned factors, the demand of the cataract surgery rises, thereby the category is expected to witness a considerable growth eventually contributing to the overall growth of the global ophthalmic surgical devices market during the forecast period.

NORTH AMERICA IS EXPECTED TO DOMINATE THE OVERALL OPHTHALMIC SURGICAL DEVICES MARKET:

Among all the regions, North America is expected to dominate the global ophthalmic surgical devices in the year 2023 and is expected to do the same during the forecast period from 2024-2030. This can be ascribed to the easy availability of technologically advanced products and high awareness among consumers about vision impairments. Further, the increasing prevalence of ophthalmic disorders, the growing demand for non-invasive or minimally invasive surgical procedures, and the presence of key market players in the region, and other factors contribute to the growth of the ophthalmic surgical devices market in North America.

For instance, according to the CDC 2022, more than 3 million Americans had glaucoma, in 2019. The source also estimated that by 2050, that number is expected to rise to 6.3 million, in the United States.

Moreover, as per the data provided by National Eye Institute (NIH) in 2022, it was concluded that every year more than half of all Americans age 80 or older either have cataracts or have had surgery to get rid of cataracts.

Additionally, the rising burden of geriatric population, increasing number of native manufacturers, and rising awareness of vision care among the people in the region will thereby increase the demand of ophthalmic surgical devices in the forecast period.

Furthermore, the increasing product launches of technological advanced products in the local market, rising investments by the key players in the region, and other activities by the key players in the region will drive the demand of ophthalmic surgical devices in the North America during the forecast period of 2022 - 2028. For instance, in October 2019 Carl Zeiss AG, announced the launch of its next-generation product, CIRRUS 6000 in the United States. The CIRRUS 6000 is an ultra-fast 100 kHz system that ensures the ophthalmologists avoid the errors and enhance the surgical procedure efficiency which directly drives for growth of the market in the region.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the Ophthalmic Surgical Devices market.

OPHTHALMIC SURGICAL DEVICES MARKET KEY PLAYERS:

Some of the key market players operating in the ophthalmic surgical devices market includes Bausch & Lomb Incorporated, Topcon Corporation, Johnson & Johnson, Carl Zeiss AG, Alcon Inc, Lumenis Ltd, Hoya Corporation, Ellex Medical Laser Ltd, STAAR Surgical Company, Ziemer Ophthalmic Systems AG, Glaukos Corporation., AbbVie., New World Medical, Inc., Oertli Instrumente AG, NIDEK CO., LTD., IRIDEX Corporation, HumanOptics, Surgical Holdings., Madhu Instruments Pvt. Ltd, GWS Surgicals LLP, and others.

RECENT DEVELOPMENTAL ACTIVITIES IN OPHTHALMIC SURGICAL DEVICES MARKET:

In April 2022, Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., announced that the U.S. Food and Drug Administration (FDA) has approved ClearVisc(TM) dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery.

In February 2022, Johnson & Johnson Vision, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies, announced that the FDA has approved the TECNIS EyhanceTM and TECNIS EyhanceTM Toric II intraocular lens (IOL) for the treatment of cataract patients in the United States.

In December 2019, Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., announced the introduction of the enVista® toric MX60ET hydrophobic acrylic intraocular lens (IOL) with StableFlex(TM) technology, which provides improved material properties to deliver enhanced optic recovery following delivery during cataract surgery.

KEY TAKEAWAYS FROM THE OPHTHALMIC SURGICAL DEVICES MARKET REPORT STUDY

  • Market size analysis for current ophthalmic surgical devices market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the ophthalmic surgical devices market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global ophthalmic surgical devices market.
  • Various opportunities available for the other competitor in the ophthalmic surgical devices market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current ophthalmic surgical devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for ophthalmic surgical devices market growth in the coming future?

TARGET AUDIENCE WHO CAN BE BENEFITED FROM THIS OPHTHALMIC SURGICAL DEVICES MARKET REPORT STUDY

  • Ophthalmic surgical devices products providers
  • Research organizations and consulting companies
  • Ophthalmic surgical devices -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in ophthalmic surgical devices
  • Various end users who want to know more about the ophthalmic surgical devices market and latest technological developments in the ophthalmic surgical devices market.

FREQUENTLY ASKED QUESTIONS FOR OPHTHALMIC SURGICAL DEVICES MARKET:

1. What is ophthalmic surgical devices?

The Ophthalmic Surgical Devices are used in retinal, refractive and cataract surgeries, and in treatment of various ophthalmic diseases such as cataract, glaucoma, and refractive error. These devices are employed majorly when the disease is not diagnosed at an early stage thus, the demand for ophthalmic surgical devices increases to prevent visual impairment and loss of vision.

2. What is the global market for ophthalmic surgical devices?

The global ophthalmic surgical devices market was valued at USD 8.91 billion in 2022 and will grow at a CAGR of 5.09% during the forecast period from 2024 to 2030 in order to reach USD 11.97 billion by 2030.

3. What are the drivers for global ophthalmic surgical devices market?

The ophthalmic surgical devices market is witnessing a positive market growth owing to the factors such as the growing prevalence of ophthalmic disorders, rising burden of geriatric population, rising prevalence of diabetes, rising awareness about the vision impairment, surging technological advancements in the devices, increasing product launches and approvals, presence of key players in the market, and others will create an exigency for the ophthalmic surgical devices market.

4. Who are the key players operating in the global ophthalmic surgical devices market?

Some of the key market players operating in the ophthalmic surgical devices market includes Bausch & Lomb Incorporated, Topcon Corporation, Johnson & Johnson, Carl Zeiss AG, Alcon Inc, Lumenis Ltd, Hoya Corporation, Ellex Medical Laser Ltd, STAAR Surgical Company, Ziemer Ophthalmic Systems AG, Glaukos Corporation., AbbVie., New World Medical, Inc., Oertli Instrumente AG, NIDEK CO., LTD., IRIDEX Corporation, HumanOptics, Surgical Holdings., Madhu Instruments Pvt. Ltd, GWS Surgicals LLP, and others.

5. Which region has the highest share in ophthalmic surgical devices market?

Among all the regions, North America is estimated to amass the significant revenue share in the global ophthalmic surgical devices market. This can be ascribed to the increasing prevalence of ophthalmic disorders, the growing demand for non-invasive or minimally invasive surgical procedures, and the presence of key market players in the region are the reasons which acts as a supportive factor for the North America ophthalmic surgical devices market growth.

Table of Contents

1. Ophthalmic Surgical Devices Market Report Introduction

2. Ophthalmic Surgical Devices Market Executive Summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Ophthalmic Surgical Devices Market Key Factors Analysis

  • 4.1 Ophthalmic Surgical Devices Market Drivers
    • 4.1.1 Growing prevalence of ophthalmic disorders
    • 4.1.2 Rising burden of geriatric population, rising prevalence of diabetes
    • 4.1.3 Rising awareness about the vision impairment
    • 4.1.4 Surging technological advancements in the devices
  • 4.2 Ophthalmic Surgical Devices Market Restraints and Challenges
    • 4.2.1 High cost of surgical devices
    • 4.2.2 Complications related to surgical procedures
    • 4.2.3 Unfavorable Reimbursement Policies Pertaining to the Ophthalmic Surgery Industry
  • 4.3 Ophthalmic Surgical Devices Market Opportunities
    • 4.3.1 Increasing demand and awareness about vision care in emerging countries

5. Ophthalmic Surgical Devices Market Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Ophthalmic Surgical Devices Market

7. Ophthalmic Surgical Devices Market Layout

  • 7.1 By Product Type
    • 7.1.1 Implants & Stents
      • 7.1.1.1 Intraocular Lenses (IOLs)
      • 7.1.1.2 Glaucoma Drainage Implants
      • 7.1.1.3 Others
    • 7.1.2 Viscoelastics (OVDs)
    • 7.1.3 Laser Surgery Devices
    • 7.1.4 Others
  • 7.2 By Application
    • 7.2.1 Cataract Surgery
    • 7.2.2 Glaucoma Surgery
    • 7.2.3 Vitreoretinal Surgery
    • 7.2.4 Refractive Surgery
    • 7.2.5 Others
  • 7.3 By End-user
    • 7.3.1 Hospitals & Clinics
    • 7.3.2 Specialty Centers
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Ophthalmic Surgical Devices Market in USD million (2021-2030)
      • 7.4.1.2 Canada Ophthalmic Surgical Devices Market in USD million (2021-2030)
      • 7.4.1.3 Mexico Ophthalmic Surgical Devices Market in USD million (2021-2030)
    • 7.4.2 Europe
      • 7.4.2.1 France Ophthalmic Surgical Devices Market in USD million (2021-2030)
      • 7.4.2.2 Germany Ophthalmic Surgical Devices Market in USD million (2021-2030)
      • 7.4.2.3 United Kingdom Ophthalmic Surgical Devices Market in USD million (2021-2030)
      • 7.4.2.4 Italy Ophthalmic Surgical Devices Market in USD million (2021-2030)
      • 7.4.2.5 Spain Ophthalmic Surgical Devices Market in USD million (2021-2030)
      • 7.4.2.6 Rest of Europe Ophthalmic Surgical Devices Market in USD million (2021-2030)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Ophthalmic Surgical Devices Market in USD million (2021-2030)
      • 7.4.3.2 Japan Ophthalmic Surgical Devices Market in USD million (2021-2030)
      • 7.4.3.3 India Ophthalmic Surgical Devices Market in USD million (2021-2030)
      • 7.4.3.4 Australia Ophthalmic Surgical Devices Market in USD million (2021-2030)
      • 7.4.3.5 South Korea Ophthalmic Surgical Devices Market in USD million (2021-2030)
      • 7.4.3.6 Rest of Asia Pacific Ophthalmic Surgical Devices Market in USD million (2021-2030)
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1. Middle East Ophthalmic Surgical Devices Market in USD million (2021-2030)
      • 7.4.4.2 Africa Ophthalmic Surgical Devices Market in USD million (2021-2030)
      • 7.4.4.3 South America Ophthalmic Surgical Devices Market in USD million (2021-2030)

8. Ophthalmic Surgical Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Ophthalmic Surgical Devices Market Company and Product Profiles

  • 9.1 Bausch & Lomb Incorporated
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Topcon Corporation
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 Johnson & Johnson
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Carl Zeiss AG
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Alcon Inc
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 Lumenis Ltd
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 Hoya Corporation
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 Ellex Medical Laser Ltd
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 STAAR Surgical Company
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Ziemer Ophthalmic Systems AG
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Glaukos Corporation.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 AbbVie.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 New World Medical, Inc.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 Oertli Instrumente AG
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 NIDEK CO., LTD.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 IRIDEX Corporation
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 HumanOptics
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 Surgical Holdings.
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy
  • 9.19 Madhu Instruments Pvt. Ltd
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4 Product Listing
    • 9.19.5. Entropy
  • 9.20 GWS Surgicals LLP
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4 Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Ophthalmic Surgical Devices Market
  • Table 3 Ophthalmic Surgical Devices Market Analysis in Global (2021-2030)
  • Table 4 Ophthalmic Surgical Devices Market Analysis in Global by Product Type (2021-2030)
  • Table 5 Ophthalmic Surgical Devices Market Analysis in Global by Application (2021-2030)
  • Table 6 Ophthalmic Surgical Devices Market Analysis in Global by End-user (2021-2030)
  • Table 7 Ophthalmic Surgical Devices Market Analysis in Global by Geography (2021-2030)
  • Table 8 Ophthalmic Surgical Devices Market Analysis in North America (2021-2030)
  • Table 9 Ophthalmic Surgical Devices Market Analysis in North America by Country (2021-2030)
  • Table 10 Ophthalmic Surgical Devices Market Analysis in the US (2021-2030)
  • Table 11 Ophthalmic Surgical Devices Market Analysis in Canada (2021-2030)
  • Table 12 Ophthalmic Surgical Devices Market Analysis in Mexico (2021-2030)
  • Table 13 Ophthalmic Surgical Devices Market Analysis in Europe (2021-2030)
  • Table 14 Ophthalmic Surgical Devices Market Analysis in Europe by Country (2021-2030)
  • Table 15 Ophthalmic Surgical Devices Market Analysis in France (2021-2030)
  • Table 16 Ophthalmic Surgical Devices Market Analysis in Germany (2021-2030)
  • Table 17 Ophthalmic Surgical Devices Market Analysis in the UK (2021-2030)
  • Table 18 Ophthalmic Surgical Devices Market Analysis in Italy (2021-2030)
  • Table 19 Ophthalmic Surgical Devices Market Analysis in Spain (2021-2030)
  • Table 20 Ophthalmic Surgical Devices Market Analysis in Rest of Europe (2021-2030)
  • Table 21 Ophthalmic Surgical Devices Market Analysis in Asia-Pacific (2021-2030)
  • Table 22 Ophthalmic Surgical Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 23 Ophthalmic Surgical Devices Market Analysis in China (2021-2030)
  • Table 24 Ophthalmic Surgical Devices Market Analysis in Japan (2021-2030)
  • Table 25 Ophthalmic Surgical Devices Market Analysis in India (2021-2030)
  • Table 26 Ophthalmic Surgical Devices Market Analysis in Australia (2021-2030)
  • Table 27 Ophthalmic Surgical Devices Market Analysis in South Korea (2021-2030)
  • Table 28 Ophthalmic Surgical Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 29 Ophthalmic Surgical Devices Market Analysis in Rest of World (2021-2030)
  • Table 30 Ophthalmic Surgical Devices Market Analysis in Rest of World by Region (2021-2030)
  • Table 31 Ophthalmic Surgical Devices Market Analysis in the Middle East (2021-2030)
  • Table 32 Ophthalmic Surgical Devices Market Analysis in Africa (2021-2030)
  • Table 33 Ophthalmic Surgical Devices Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Ophthalmic Surgical Devices Market
  • Figure 3 Ophthalmic Surgical Devices Market Analysis in Global (2021-2030)
  • Figure 4 Ophthalmic Surgical Devices Market Analysis in Global by Product Type (2021-2030)
  • Figure 5 Ophthalmic Surgical Devices Market Analysis in Global by Application (2021-2030)
  • Figure 6 Ophthalmic Surgical Devices Market Analysis in Global by End-user (2021-2030)
  • Figure 7 Ophthalmic Surgical Devices Market Analysis in Global by Geography (2021-2030)
  • Figure 8 Ophthalmic Surgical Devices Market Analysis in North America (2021-2030)
  • Figure 9 Ophthalmic Surgical Devices Market Analysis in North America by Country (2021-2030)
  • Figure 10 Ophthalmic Surgical Devices Market Analysis in the US (2021-2030)
  • Figure 11 Ophthalmic Surgical Devices Market Analysis in Canada (2021-2030)
  • Figure 12 Ophthalmic Surgical Devices Market Analysis in Mexico (2021-2030)
  • Figure 13 Ophthalmic Surgical Devices Market Analysis in Europe (2021-2030)
  • Figure 14 Ophthalmic Surgical Devices Market Analysis in Europe by Country (2021-2030)
  • Figure 15 Ophthalmic Surgical Devices Market Analysis in France (2021-2030)
  • Figure 16 Ophthalmic Surgical Devices Market Analysis in Germany (2021-2030)
  • Figure 17 Ophthalmic Surgical Devices Market Analysis in the UK (2021-2030)
  • Figure 18 Ophthalmic Surgical Devices Market Analysis in Italy (2021-2030)
  • Figure 19 Ophthalmic Surgical Devices Market Analysis in Spain (2021-2030)
  • Figure 20 Ophthalmic Surgical Devices Market Analysis in Rest of Europe (2021-2030)
  • Figure 21 Ophthalmic Surgical Devices Market Analysis in Asia-Pacific (2021-2030)
  • Figure 22 Ophthalmic Surgical Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 23 Ophthalmic Surgical Devices Market Analysis in China (2021-2030)
  • Figure 24 Ophthalmic Surgical Devices Market Analysis in Japan (2021-2030)
  • Figure 25 Ophthalmic Surgical Devices Market Analysis in India (2021-2030)
  • Figure 26 Ophthalmic Surgical Devices Market Analysis in Australia (2021-2030)
  • Figure 27 Ophthalmic Surgical Devices Market Analysis in South Korea (2021-2030)
  • Figure 28 Ophthalmic Surgical Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 29 Ophthalmic Surgical Devices Market Analysis in Rest of World (2021-2030)
  • Figure 30 Ophthalmic Surgical Devices Market Analysis in Rest of World by Region (2021-2030)
  • Figure 31 Ophthalmic Surgical Devices Market Analysis in the Middle East (2021-2030)
  • Figure 32 Ophthalmic Surgical Devices Market Analysis in Africa (2021-2030)
  • Figure 33 Ophthalmic Surgical Devices Market Analysis in South America (2021-2030)
  • Figure 34 Market Drivers
  • Figure 35 Market Barriers
  • Figure 36 Market Opportunities
  • Figure 37 PORTER's Five Force Analysis